Covered recipient · General Payments record
TAUSEEF QURESHI
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$6,075.54
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $420.22 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $110.26 | 4 |
| Inari Medical, Inc. | $86.54 | 1 |
| GlaxoSmithKline, LLC. | $77.20 | 3 |
| Respicardia, Inc. | $47.67 | 4 |
| BAXTER HEALTHCARE | $38.72 | 1 |
| Relypsa, Inc. | $24.11 | 1 |
| GENZYME CORPORATION | $18.10 | 1 |
| Inspire Medical Systems, Inc. | $17.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.69 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105340366 | CMS |
| ABBVIE INC. | $28.57 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105340370 | CMS |
| ABBVIE INC. | $29.39 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105340374 | CMS |
| ABBVIE INC. | $25.61 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105340378 | CMS |
| Baxter Healthcare | $38.72 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118294798 | CMS |
| GENZYME CORPORATION | $18.10 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139720642 | CMS |
| GlaxoSmithKline, LLC. | $27.63 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116502089 | CMS |
| GlaxoSmithKline, LLC. | $16.91 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116401753 | CMS |
| GlaxoSmithKline, LLC. | $32.66 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116439447 | CMS |
| Inari Medical, Inc. | $86.54 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140157455 | CMS |
| Inspire Medical Systems, Inc. | $17.62 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148098864 | CMS |
| Vifor Pharma, Inc. | $24.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124054620 | CMS |
| ZOLL Respicardia, Inc. | $18.25 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146936646 | CMS |
| ZOLL Respicardia, Inc. | $18.26 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146936650 | CMS |
| ZOLL Respicardia, Inc. | $5.58 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146936648 | CMS |
| ZOLL Respicardia, Inc. | $5.58 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146936652 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.